Geneva Health Forum Archive

Browse and download abstracts, posters, documents and videos from past editions of the GHF

Pascal Lamy

PascalLamyPascal Lamy

Director-General of the WTO from September 2005 to August 2013

Mr. Lamy holds degrees from the Paris based Ecole des Hautes Études Commerciales (HEC), from the Institut d’Etudes Politiques (IEP) and from the Ecole Nationale d’Administration (ENA). He began his career in the French civil service at the Inspection Générale des finances and at the Treasury. He then became an advisor to the Finance Minister Jacques Delors, and subsequently to Prime Minister Pierre Mauroy.

In Brussels from 1985 to 1994, Pascal Lamy was Chief of staff for the President of the European Commission, Jacques Delors, and his representative as Sherpa in the G7.

In November 1994, he joined the team in charge of rescuing Credit Lyonnais, and later became CEO of the bank until its privatisation in 1999.

Between 1999 and 2004, Pascal Lamy was Commissioner for Trade at the European Commission under Romano Prodi.

After his tenure in Brussels, Pascal Lamy spent a short sabbatical period as President of “Notre Europe”, a think tank working on European integration, as associate Professor at the l’Institut d’études politiques in Paris and as advisor to Poul Nyrup Rasmussen (President of the European Socialist Party).

Mira Shiva

MiraShiva200x150Dr Mira Shiva

Chairperson, Health Action International Asia -Pacific Founder, People's Health Movement

Born to a Gandhian mother and a forest conservator father, a qualified doctor herself, Dr Mira Shiva chose to live the life of an activist. Single by choice in a man's world, Shiva has not just left her mark but has successfully made a difference to society…

Her journey started from Ludhiana in 1968, when she was doing her MD from Christian Medical College. When Dr Mira Shiva was a student, she observed women were dying during child birth and the college was making efforts to prepare doctors for situations like these. It was in this college that Shiva met Dr Betty Cowan, a Professor of Medicine and Community Health who later became her inspiration. "In her I found a person motivated by community health concerns," says Shiva.

Turning point

Shiva happened to be in Bihar in 1979-80 when there was an outburst of tuberculosis in the area. "There was a spread of tuberculosis and there were no anti TB drugs available in that area. All irrational hazardous combinations were flooding the market. That was the time that I felt the pain in my heart and thought that I must take this up with the chemical ministry," recalls Shiva. This marked the major turning point in her life.

Thereafter, Shiva has never looked back. She knew what she wanted to do next. Confident in her thoughts, she followed her mind. "I always wanted to become a doctor and practice medicine but I also wanted to serve human kind," she says.

Making a difference

Shiva has made many remarkable efforts in order to make this world a better place to live in. She has been associated with civil society bodies and has been part of many government committees representing the voice of masses.

Shiva was a member of the Drug Pricing Review Committee in 2001, as well as the Chemicals Ministry and the R& D Committee in the same year. Besides, she has played an important role as a member of various bodies like the Central Council for Health, National Population Commission, National Advisory Committee on Assisted Reproductive Technologies and National Human Rights Commission. She was also on the Task Force on Safety of Food and Medicine and was Chairperson of the Task Force on Consumer Education. Shiva is also associated with civil society bodies like Health Equity and Society, All India Drug Action Network and Health Action International Asia Pacific. She is a founder member of Peoples Health Movement and a steering committee member of Diverse Women for Diversity.

But is it easy for a woman activist to fight for rights of women and poor people amidst powerful men? "There are always men to de-legitimise my presence but I am always too firm to make my way and tell them my purpose to be there. The fact that I happened to be a woman is not so important to me," declares Shiva. She has rather learned from her experience to handle people and she feels it is important for every woman to do so too. "It is important to understand that you are saying what you are saying and being a woman does not mean that you are asking for a favour," she adds.

For namesake

The lady, who named herself after Mira Bai, says that she knew that she was born to become a rebel. "I named myself after Mira Bai because people tried to kill her in three different ways but failed. I draw my inspiration from there," she says. However, born to a family with liberal thoughts, Shiva gets her strength from her Gandhian mother, who was a writer and faced odds in her life as well, as well as her grandfather, who had set up a school for girls in rural areas. Her parents were very supportive of her decisions and gave her the freedom to choose. "I got it as a sanskar that I am no less than others and that there is no difference between a boy and a girl. If you underestimate me as a girl you are asking for trouble," she declares.

But women often face attacks on their identity from a patriarchal society. So did Shiva. "I have been repeatedly addressed as ‘Mrs Mira Shiva’ and by people who know my status but each time I used to make it a point to raise my voice and correct them …I will tell them I am not Mrs Mira Shiva but Dr Mira Shiva…It has something to do with my identity and it is important to me. People try to weaken you through such means. They would tell me that I am acting non-professional and speaking for a certain section which is not true," she says. Shiva points out that men occupying positions of power expect women to follow instructions and agree with them on whatever they say, so she was naturally not like by them. But she wonders, had she been born a man , then would the reaction from men be similar? The question remains unanswered …

Recep Akdag

RecepAkdagSquareRecep Akdag

Minister of Health of Turkey 2002 - 2013

Recep Akdag was born in Erzurum, Turkey in 1960. As a pediatrician, he has been holding a professor title from the Ataturk University School of Medicine since 1999. During his career as a medical specialist and academician, he had been involved in a number of administrative tasks. Between 1994 and 1998, he worked as the Deputy Chief Medical Director, Chairman of the Procurement Commission and Deputy Editor of the Medical Bulletin in the Research Hospital of the Medical Faculty of Ataturk University. He also co-founded the Biotechnology Research Center of the University and served as the Deputy Head of the Center from 1997 to 2000.

After being elected as a Member of Parliament from the Province of Erzurum, he had served as the Minister of Health of Turkey between 2002 and 2013. During his tenure, he has been the key figure for the implementation of the influential Health Transformation Program (HTP) in Turkey. This comprehensive program brought a people-oriented approach to healthcare service delivery and strengthened the health system with successful implementation of universal health coverage. Major aspects of this health system reform included integration of public hospitals, increased patient access to medical services and prescription drugs, invigorated primary healthcare delivery with the implementation of family medicine, improved maternal and childhood healthcare services, better quality and reach of emergency services, and establishment of a national medical rescue team.

HTP generated high access rate for essential services thru the adequate healthcare supply and universal health insurance covering the poorest. Infant mortality rate, maternal mortality ratio and catastrophic health expenditures decreased dramatically. Public satisfaction with health services increased from 39% in 2002 to 75% in 2012. Apart from leading this influential program, Prof. Akdag has edited a number of reports and contributed/co-authored academic articles about HTP. He has addressed, directed and moderated in many international conferences including of those the WHO and UNICEF. He has received the WHO’s “World No Tobacco Day” Award as a recognition of his efforts in the fight against the global tobacco epidemic and in the promotion of tobacco control initiatives and policies. He has been an advisory board member of the Ministerial Leadership in Health (MLIH) Program at Harvard University since 2012.

Prof. Akdag still serves as an MP in the Grand National Assembly of Turkey for his third consecutive term. He also is a Richard L. and Ronay A. Menschel Senior Leadership Fellow, Harvard School of Public Health.

 

Bart Peterson

BartPetersonSMBart Peterson

Senior Vice President, Corporate Affairs and Communications at Ely Lilly

Bart Peterson joined Eli Lilly and Company in June 2009 as senior vice president of corporate affairs and communications. He is a member of the company’s executive committee.

Peterson received a bachelor’s degree from Purdue University in 1980 and earned his law degree at the University of Michigan in 1983.

Prior to joining Lilly, Peterson was Managing Director at Strategic Capital Partners, LLC from June 2008 to June 2009. During spring 2008, Peterson was a fellow with the Institute of Politics of Harvard University’s Kennedy School of Government. During the 2008-2009 school year, Peterson was a Distinguished Visiting Professor of Public Policy at Ball State University. He continues as a fellow with the University’s Bowen Center for Public Affairs.

From 2000 to 2007, Peterson served two terms as Mayor of Indianapolis, the nation’s 12th largest city. He also served as President of the National League of Cities in 2007. As mayor, Peterson led a transformation of public education in Indianapolis as the only mayor in America with the authority to create new schools by issuing charters. He was responsible for 16 charter schools and won Harvard University’s prestigious Innovations in American Government Award for the initiative in 2006. He was also instrumental in the business expansions of FedEx, Rolls Royce, and WellPoint in Indianapolis, and the construction and development of major projects such as Lucas Oil Stadium, the Conrad Indianapolis, Simon Property Group’s world headquarters, the new Indianapolis International Airport’s Col. H. Weir Cook terminal building, and the future Indiana Convention Center expansion and J.W. Marriott Hotel.

Along with Indiana University, Purdue University, Lilly, and the Central Indiana Corporate Partnership, he created BioCrossroads, a focused effort to push Indianapolis to the forefront as a life sciences capital. Peterson was honored by the National Association of Clean Water Agencies with their city government leader of the year award for his efforts in cleaning up the Indianapolis waterways.

Prior to running for office, Peterson served as a member of Indiana Governor Evan Bayh’s leadership team, first as his aide for environmental affairs and later as chief of staff, and was an attorney with IceMiller, an Indianapolis law firm.

Peterson is a founding member and board chair of The Mind Trust, a non-profit organization promoting education reform. He is also a board member of the Regenstrief Foundation and Christian Theological Seminary, as well as a member of the Board of Advisors for Ball State University’s Bowen Center for Public Affairs, and the Board of Directors of Kite Realty Group. In 2012, Peterson was appointed by the US State Department to the Asia-Pacific Economic Cooperation (APEC) Business Advisory Council.

Irene Akua Agyepong

irene-agyepongIrene Akua Agyepong

MBChB, DRPH, Regional Director of Health Services (Ghana Health Service), part-time Lecturer (University of Ghana)

Irene has over 15 years experience in public health practice, research and teaching.  She was a professor in the University of Utrecht as holder of the Prince Claus Chair in equity and development from 2008 to 2010.  Her interests are in health policy development and implementation, public health leadership and health policy and systems research.   She is currently the regional Director of Health Services, Ghana Health Service in the Greater Accra Region and also teaches part-time in the HPPM department School of Public Health of the University of Ghana, Legon.  She is Chair of the Scientific and Technical Advisory Committee (STAC) of the Alliance for Health Policy and Systems Research, WHO Geneva.

Peter Maurer

peter-maurer-presidentPeter Maurer

President of the ICRC

Peter Maurer was born in Thun, Switzerland, in 1956. He studied history and international law in Bern, where he was awarded a doctorate. In 1987 he entered the Swiss diplomatic service, where he held various positions in Bern and Pretoria before being transferred to New York in 1996 as deputy permanent observer at the Swiss mission to the United Nations. In 2000 he was appointed ambassador and head of the human security division in the political directorate of the Swiss Department of Foreign Affairs in Bern.

In 2004 Mr Maurer was appointed ambassador and permanent representative of Switzerland to the United Nations in New York. In this position, he worked to integrate Switzerland, which had only recently joined the United Nations, into multilateral networks. In June 2009, the UN General Assembly elected Mr Maurer chairman of the Fifth Committee, in charge of administrative and budgetary affairs. In addition, he was elected chairman of the Burundi configuration of the UN Peacebuilding Commission. In January 2010 Mr Maurer was appointed secretary of State for foreign affairs in Bern and took over the reins of the Swiss Department of Foreign Affairs, with its five directorates and some 150 Swiss diplomatic missions around the world. He succeeded Jakob Kellenberger as ICRC president on 1 July 2012.

Dr Rifat Atun

RifatAtunDr Rifat Atun is Professor of Global Health Systems at Harvard University, where he is the Director of Global Health Systems Cluster at Harvard University's School of Public Health.

In 2006-13, Dr Atun was Professor of International Health Management and Head of the Health Management Group at Imperial College London. He is an Honorary Professor at the London School of Hygiene and Tropical Medicine. In 2008-12 he served as a member of the Executive Management Team of The Global Fund to Fight AIDS, Tuberculosis and Malaria as the Director of Strategy, Performance and Evaluation Cluster.

Rifat's research focuses on the design and implementation of health systems transformations and their impact on outcomes. His research also explores adoption and diffusion of innovations in health systems (e.g. health technologies, disease control programmes, and primary healthcare reforms), and innovative financing in global health. Organization. Rifat is a co-Investigator and the joint lead for the innovation work stream at the National Centre for Infection Prevention and Management at Imperial College. He is also a co-Investigator and the Theme Lead for 'Organisational Change, Sustainability and Evaluation' at Imperial College and Cambridge University Health Protection Research Unit for Antimicrobial Resistance and Healthcare Associated Infection. He has published widely in the Lancet, PLoS Medicine, Lancet Infectious Diseases, BMJ, AIDS, and Bulletin of the World Health Organization.

Rifat has worked with several governments globally and with the World Bank, World Health Organization, and the UK Department for International Development to design, implement and evaluate health system reform initiatives in more than 20 countries. He has led research and consultancy projects for GSK, Pfizer Inc., the Vodafone Group, Hofmann La Roche,  PA Consulting, and Tata Consulting Services.

Rifat was the Founding Director of the MSc in International Health Management, BSc in Management and Medical Science, and Founding Co-Director of the Masters in Public Health Programme at Imperial College. He has been a director of Imperial College spin out companies operating in areas of health technology.

Rifat is a member of the MRC Global Health Group as the MRC Infections and Immunity Board representative. He serves as  a member of the PEPFAR Scientific Advisory Board, the Norwegian Research Council's Global Health and Vaccination Research (GLOBVAC) Board, the Research Advisory Committee for the Public Health Foundation of India, and the US Institute of Medicine USAID Standing Committee on Strengthening Health Systems. In 2006-08 he served as a Member of the Advisory Committee for WHO Research Centre for Health Development in Japan. He was member of the Strategic Technical Advisory Group of the WHO for Tuberculosis and chaired the WHO Task Force on Health Systems and Tuberculosis Control. In 2009-12 he was the Chair of the STOP TB Partnership Coordinating Board.

Rifat is a Fellow of the Royal College of General Practitioners (UK), Fellow of the Faculty of Public Health of the Royal College of Physicians (UK), and a Fellow of the Royal College of Physicians (UK).